JPRN-UMIN000039889已完成未知
Evaluation of the efficacy of romosozumab for hemodialysis patients with hemodialysis - Evaluation of the efficacy of romosozumab for hemodialysis patients with hemodialysis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who are not receiving standard treatment for osteoporosis 2)Persons who are contraindicated in taking evenity or denosumab 3)Patients who have taken romosozumab or denosumab within 6 months 4)Hypocalcemia 5)Patients with severe liver dysfunction, heart dyfunction, malignant tumor 6)Patients who are judged by the investigator not to be eligible for drug administration.
研究者
相似试验
招募中
不适用
Evaluation of efficacy and safety of romosozumab administration group and ibandronate sodium hydrate administration group for osteoporosis patients after denosumab treatmentosteoporosisJPRN-UMIN000037394Shinshu University School of Medicine Dept. of Orthopaedic Surgery60
招募中
不适用
Evaluation of the efficacy of romosozumab for glucocorticoid-induced osteoporosis in long-term glucocorticoid administration patientsglucocorticoid-induced osteoporosisJPRN-UMIN000037240Toho University School of Medicine Division of Rheumatology, Department of Internal Medicine200
招募中
不适用
Evaluation of the efficacy of romosozumab for glucocorticoid-induced osteoporosis in initial glucocorticoid administration patientsglucocorticoid-induced osteoporosisJPRN-UMIN000037239Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine90
尚未招募
不适用
Evaluation of the efficacy and safety of romosozumab alone and romosozumab + denosumab combination for patients with osteoporosis treated with 2-year denosumabosteoporosisJPRN-UMIN000037123Shinshu University School of Medicine Dept. of Orthopaedic Surgery60
招募中
1 期
The OPTIMIST studyosteoporosisCTIS2023-505940-20-00Region Midtjylland270